cache/d96e994cb7af86874020392c827fe3576376ef235f5e72bd9af434942ef75b6d

    COM:QUESTACAPITAL

    Calyxo, Inc.

    • Privately Held

    Description

    Calyxo, Inc. is a clinical-stage medical device company focused on developing and commercializing innovative solutions for kidney stone disease. The company's lead product, CVac, is designed to prevent the recurrence of kidney stones through a minimally invasive procedure that aims to alter the urinary environment to prevent stone formation.

    peer of

    invested in